Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
about
Venous thromboembolic diseaseEvaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction.Heparin-induced thrombocytopenia: treatment options and special considerations.Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.Argatroban in the management of heparin-induced thrombocytopenia.Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Clinical experience with argatroban for heparin-induced thrombocytopenia in a large teaching hospital.The Pharmacotherapy of Heparin-Induced Thrombocytopenia (HIT) : A Review of Contemporary Therapeutic Challenges in Clinical Practice.Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type IIEfficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.Comparisons of argatroban to lepirudin and bivalirudin in the treatment of heparin-induced thrombocytopenia: a systematic review and meta-analysis.
P2860
Q24631121-5BFFA887-18BA-4392-96DA-C51D723DFCC0Q33370636-09C90107-624D-4D6A-B700-686BCAB1AA8FQ33374658-51248356-1A12-4008-8808-6B3375C8254FQ33375376-4BE6825C-1560-48E0-9728-8A6BE4F25BBCQ33380931-3DEB452C-C4DE-411D-9F1F-E51184035E61Q33391969-704B4385-DCAA-4374-AFB2-0036E3FEDE42Q33394199-9712FA40-49A1-45CC-8F39-3F15D9F97A5EQ33399580-BC45724D-F4E3-4EC9-99F1-E42B6B1D9B1EQ33400597-9E9AC28E-8F1C-4495-9B5C-DFF374451EACQ33401236-CE924767-C09B-47CD-B5F5-79DE80988386Q33417258-448AAD55-6BD3-4B65-8FA5-E7F05A42A6D2Q33419374-4CA433EB-3E44-48F5-B998-06DF8ABCE30DQ33442600-9344566A-DB7E-411F-941E-74F2B2967C2E
P2860
Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Evaluation of diagnostic tests ...... arin-induced thrombocytopenia.
@ast
Evaluation of diagnostic tests ...... arin-induced thrombocytopenia.
@en
type
label
Evaluation of diagnostic tests ...... arin-induced thrombocytopenia.
@ast
Evaluation of diagnostic tests ...... arin-induced thrombocytopenia.
@en
prefLabel
Evaluation of diagnostic tests ...... arin-induced thrombocytopenia.
@ast
Evaluation of diagnostic tests ...... arin-induced thrombocytopenia.
@en
P2093
P2860
P1433
P1476
Evaluation of diagnostic tests ...... arin-induced thrombocytopenia.
@en
P2093
Douglas N Fish
Robert MacLaren
P2860
P304
P356
10.1592/PHCO.2005.25.12.1736
P407
P577
2005-12-01T00:00:00Z